Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 4.500
0.00 (0.00%)
Apr 29, 2026, 5:03 PM CET
STO:MAGLE Market Cap
STO:MAGLE has a market cap or net worth of 92.92 million as of May 1, 2026. Its market cap has decreased by -86.19% in one year.
Market Cap
92.92M
Enterprise Value
425.52M
Revenue
287.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.50
Market Cap Chart
Since June 30, 2020, STO:MAGLE's market cap has decreased from 205.10M to 92.92M, a decrease of -54.69%. That is a compound annual growth rate of -12.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 92.92M | -74.43% |
| Dec 30, 2025 | 363.43M | -43.25% |
| Dec 30, 2024 | 640.39M | 135.30% |
| Dec 29, 2023 | 272.16M | -5.97% |
| Dec 30, 2022 | 289.44M | -10.37% |
| Dec 30, 2021 | 322.92M | -29.72% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 122.76M |
| Simris Group AB (PUBL) | 121.21M |
| IRLAB Therapeutics AB | 119.59M |
| Annexin Pharmaceuticals AB | 104.47M |
| Biovica International AB | 102.17M |
| Scandinavian ChemoTech AB | 101.56M |
| OncoZenge AB | 84.29M |
| AcouSort AB | 83.39M |